Skip to content

Treatment Of Intra Uterine Growth Retardation Using Vidaryadi Ghrita And L-ARGININE

A Comparative Clinical Study To Evaluate The Effect Of Vidaryadi Ghrita Matra Basti And L-Arginine In The Management Of Iugr

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021382
Enrollment
40
Registered
2019-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Vidaryadi Ghrita: Used For - Basti Route Of Administration - Anal Route Dose -60 Ml Daily Once Duration - 21 Days Control Intervention1: L-ARGININE: Route Of Administration - Oral D

Sponsors

Dept of Prasooti Tantra Stri Roga
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Both primi-gravida and multi-gravida of age group 18 to 35yrs 2.Single Live Intrauterine Gestation between 28 to 36 weeks fulfilling diagnostic criteria

Exclusion criteria

Exclusion criteria: 1.Who is contra- indicated for basti 2.Fetal anomaly. 3.Chorioamnionitis, Per vaginal leaking. 4.Severe anemia (less than 7/8gm%, acute Oligohydramnios due to fever, loose stools). 5.Chronic infections like Tuberculosis, HIV, Hepatitis B, and TORCH. 6.High risk pregnancy with conditions like PIH and diabetes. 7.Multiple pregnancy.

Design outcomes

Primary

MeasureTime frame
â?¢Increase In Fetal Movement â?¢Increase In Fundal Height â?¢Increase In Fetal Weight Including Bpd , Fi , Ac , Hc , And Afi Timepoint: 21 DAYS

Secondary

MeasureTime frame
Improvement Of The Fetal Movements And Abdominal Girth Along With Improvement In Overall Health Of The FetusTimepoint: 21 days

Countries

India

Contacts

Public ContactDr Sridevi M

S.J.G.ayurvedic medical college

dr.sridevi.ireddy@gmail.com9448491758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026